Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 19767089

High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2009 Oct 31
First author
Ferreri AJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2009 Oct 31;374(9700):1477-8. doi: 10.1016/S0140-6736(09)61488-4.
    note
    Source null
    related pmid
    19767091
    relationship
    Comment in
  2. citation
    Curr Neurol Neurosci Rep. 2011 Jun;11(3):243-5. doi: 10.1007/s11910-011-0183-1.
    note
    Source null
    related pmid
    21271308
    relationship
    Comment in

Authors and identifiers

  1. name
    Ferreri AJ
    type
    Author
  2. name
    Reni M
    type
    Author
  3. name
    Foppoli M
    type
    Author
  4. name
    Martelli M
    type
    Author
  5. name
    Pangalis GA
    type
    Author
  6. name
    Frezzato M
    type
    Author
  7. name
    Cabras MG
    type
    Author
  8. name
    Fabbri A
    type
    Author
  9. name
    Corazzelli G
    type
    Author
  10. name
    Ilariucci F
    type
    Author
  11. name
    Rossi G
    type
    Author
  12. name
    Soffietti R
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Ferreri AJ
    type
    Author
  2. name
    Reni M
    type
    Author
  3. name
    Foppoli M
    type
    Author
  4. name
    Martelli M
    type
    Author
  5. name
    Pangalis GA
    type
    Author
  6. name
    Frezzato M
    type
    Author
  7. name
    Cabras MG
    type
    Author
  8. name
    Fabbri A
    type
    Author
  9. name
    Corazzelli G
    type
    Author
  10. name
    Ilariucci F
    type
    Author
  11. name
    Rossi G
    type
    Author
  12. name
    Soffietti R
    type
    Author
bibliography ids
  1. nci-bib-e068d5ef785d01d9628ea9c2
book metadata
content sha256
5e175cc24f8a86205f04c5f7ba0bd1d1d761e92c778a61ad90a9523deaed7ac9
document type
citation
dois
  1. 10.1016/S0140-6736(09)61416-1
electronic publication date
display
2009 Sep 18
precision
day
year
2009
evidence scope
bibliographic_metadata_only
id
pubmed:19767089
immutable id
pubmed:19767089@5e175cc24f8a86205f04c5f7ba0bd1d1d761e92c778a61ad90a9523deaed7ac9
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
9700
name
Lancet (London, England)
nlm unique id
2985213R
pages
1512-20
volume
374
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2009 Oct 31;374(9700):1477-8. doi: 10.1016/S0140-6736(09)61488-4.
    note
    Source null
    related pmid
    19767091
    relationship
    Comment in
  2. citation
    Curr Neurol Neurosci Rep. 2011 Jun;11(3):243-5. doi: 10.1007/s11910-011-0183-1.
    note
    Source null
    related pmid
    21271308
    relationship
    Comment in
outcomes validated
false
pmid
19767089
provenance
batch id
0706b5111d1451f52f74
provider
NCBI PubMed ESummary
record sha256
d35ef5c25878b0df718d22932a2aeb76d94722678d3ce436c4147673f31ab5a8
response sha256
98b7635e326dbc32198e6976da57b1b6c18df77505740dee0ce67d80260cda70
retrieved at
2026-09-09T23:46:29.215195+00:00
publication date
display
2009 Oct 31
precision
day
year
2009
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/19767089/
title
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.

Preserved source evidence · Not medical advice